Skip to main content

Your search for “mitochondrial disease” returned 60 results

High Levels of Protein p62 Predict Liver Cancer Recurrence

May 19, 2016

Researchers at University of California San Diego School of Medicine and Sanford Burnham Prebys Medical Discovery Institute have discovered that high levels of the protein p62 in human liver samples are strongly associated with cancer recurrence and reduced patient survival. In mice, they also found that p62 is required for…

Drug Treatment Corrects Autism Symptoms in Mouse Model

March 13, 2013

Autism results from abnormal cell communication. Testing a new theory, researchers at the University of California, San Diego School of Medicine have used a newly discovered function of an old drug to restore cell communications in a mouse model of autism, reversing symptoms of the devastating disorder.

Century-Old Drug Reverses Autism-like Symptoms in Fragile X Mouse Model

January 15, 2015

Researchers at UC San Diego School of Medicine previously reported that a drug used for almost a century to treat trypanosomiasis, or sleeping sickness, reversed environmental autism-like symptoms in mice. Now, a new study published in this week’s online issue of Molecular Autism, suggests that a genetic form of autism-like…

UC San Diego Receives $1.3M from W. M. Keck Foundation to Study Origins of Dementia

August 16, 2022

Researchers at the University of California San Diego have received a $1.3 million grant from the W.M. Keck Foundation for a project that could help scientists better understand the role misfolded tau proteins play in causing neurodegenerative diseases like dementia, which may lead to more effective

Liquid Droplets Shape How Cells Respond to Change

April 22, 2024

New research by scientists at University of California San Diego has shown that cells regulate cAMP/PKA signaling by forming liquid droplets that segregate excess PKA catalytic subunits where they can do no harm. Some cancers may block the formation of liquid droplets, leading to hyperactive signaling and tumor formation.

Metabolism May Play Role in Recurrent Major Depression

January 12, 2021

Researchers at UC San Diego School of Medicine, in collaboration with Dutch scientists, have found that certain metabolites — small molecules produced by the process of metabolism — may be predictive indicators for persons at risk for recurrent major depressive disorder.

Chronic Diseases Driven by Metabolic Dysfunction

September 7, 2018

…cancer, diabetes and cardiovascular disease defy easy explanation, let alone remedy. In a new paper, a researcher at University of California San Diego School of Medicine, posits that chronic disease is essentially the consequence of the natural healing cycle becoming blocked, specifically by disruptions at the metabolic and cellular levels.

Common Diabetes Drug Shows Promise as Treatment for COVID-19 Lung Inflammation

June 8, 2021

Researchers identify molecular mechanism for the anti-inflammatory activity of diabetes drug metformin and, in mouse studies, say it prevents lung inflammation in animals infected with SARS-CoV-2, the virus that causes COVID-19.

UC San Diego Launches New Nonalcoholic Fatty Liver Disease Research Center

February 8, 2016

…have nonalcoholic fatty liver disease (NAFLD), a chronic condition that can lead to cirrhosis, liver cancer and liver failure. Combining a diverse array of basic science, biomarkers, imaging and clinical efforts, University of California, San Diego School of Medicine has launched a new NAFLD Research Center to better understand the…

New Mouse Model Points to Therapy for Liver Disease

August 18, 2014

In a paper published online in Cancer Cell, scientists at the University of California, San Diego School of Medicine describe a novel mouse model that closely resembles human NASH and use it to demonstrate that interference with a key inflammatory protein inhibits both the development of NASH and its progression…

Category navigation with Social links